Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:OPHT

IVERIC bio (OPHT) Stock Price, News & Analysis

IVERIC bio logo

About IVERIC bio Stock (NASDAQ:OPHT)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$1.13
$1.39
52-Week Range
N/A
Volume
N/A
Average Volume
159,109 shs
Market Capitalization
$1.65 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive OPHT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IVERIC bio and its competitors with MarketBeat's FREE daily newsletter.

OPHT Stock News Headlines

Gossamer Bio Inc GOSS
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
Baird Downgrades IVERIC bio (ISEE)
See More Headlines

OPHT Stock Analysis - Frequently Asked Questions

IVERIC bio, Inc. (NASDAQ:OPHT) posted its quarterly earnings results on Wednesday, October, 31st. The biopharmaceutical company reported ($0.41) EPS for the quarter, topping analysts' consensus estimates of ($0.43) by $0.02.

Based on aggregate information from My MarketBeat watchlists, some other companies that IVERIC bio investors own include iShares Preferred and Income Securities ETF (PFF), Puma Biotechnology (PBYI), Incyte (INCY), Apollo Investment (AINV), BioMarin Pharmaceutical (BMRN), Meta Platforms (META) and Bristol Myers Squibb (BMY).

Company Calendar

Last Earnings
10/31/2018
Today
7/14/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:OPHT
CIK
1410939
Fax
N/A
Employees
35
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.67)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$63.09 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-141.53%
Return on Assets
-41.88%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
10.09
Quick Ratio
10.09

Sales & Book Value

Annual Sales
$209.98 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.00 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
41,420,000
Free Float
N/A
Market Cap
$1.65 billion
Optionable
Optionable
Beta
1.49
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:OPHT) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners